16th Jan 2020 18:15
(Alliance News) - Open Orphan PLC on Thursday said its shares had been readmitted to trading on London's junior AIM market following its takeover of clinical development services provider hVIVO PLC.
The drug consulting firm in December had agreed terms for a reverse takeover of hVIVO.
On Thursday, Open Orphan confirmed that it would be readmitted, and expected a market capitalisation of GBP29.6 million upon admission, reflecting a total of 445.6 million shares. The company said it expects no capital to be raised on admission.
Open Orphan shares closed 1.5% up at 6.75 pence each on Thursday in London.
By Ife Taiwo; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
ORPH.L